The Hair Loss Encyclopedia

Search

for
Search:

GlossaryCetuximab

monoclonal antibody used to treat certain cancers by targeting EGFR

Cetuximab, also known by the brand name Erbitux, is a monoclonal antibody used in cancer treatment. It works by targeting the epidermal growth factor receptor (EGFR) on the surface of cancer cells, inhibiting their growth and survival. This drug is commonly used to treat certain types of head, neck, and colorectal cancers.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 153 results

Trichomegaly of the Eyelashes Following Treatment with Cetuximab

research Trichomegaly of the Eyelashes Following Treatment with Cetuximab

78 citations, June 2005 in “Annals of oncology”

Cetuximab can cause excessive eyelash growth.

research Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic and Dermatologic Cooperation

42 citations, January 2008 in “Clinical colorectal cancer”

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer

research Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer

35 citations, May 2008 in “Journal of Clinical Oncology”

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Cetuximab-Associated Elongation of the Eyelashes

research Cetuximab-Associated Elongation of the Eyelashes

30 citations, August 2010 in “American Journal of Clinical Dermatology”

Cetuximab can cause eyelash growth, which is rare but manageable.

research Incidence and Management of Cutaneous Toxicities Associated with Cetuximab

30 citations, March 2007 in “Expert opinion on drug safety”

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

View more "cetuximab" in research →

Community Join

0 / 0 results

— no results